Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

19 records shown

Women’s healthPRM 0284
Dosage formTablets
Oral

Cabergoline 0.25 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 0285
Dosage formTablets
Oral

Cabergoline 0.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 0001
Dosage formVaginal pessary
Vaginal

Clindamycin 100 mg, Clotrimazole 200 mg

Route
Vaginal
Formulation type
Vaginal solid pessary
Pharmacological class
Antifungal
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 3408
Dosage formTablets
Oral

Dinoprostone (PGE2) 0.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Prostaglandin uterotonic / cervical ripening agent
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 1886
Dosage formLiquid injectables
Parenteral

Hydroxyprogesterone 250 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 1887
Dosage formLiquid injectables
Parenteral

Hydroxyprogesterone 500 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 0888
Dosage formTablets
Oral

Isoxsuprine 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 368
Women’s healthPRM 0889
Dosage formTablets
Oral

Isoxsuprine 10 mg (SR)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 368
Women’s healthPRM 0890
Dosage formTablets
Oral

Isoxsuprine 40 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 360
Women’s healthPRM 0891
Dosage formTablets
Oral

Isoxsuprine 40 mg (SR)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 360
Women’s healthPRM 1054
Dosage formTablets
Oral

Mifepristone 200 mg, Misoprostol 200 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gastroprotective agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 4153
Dosage formTablets
Oral

Misoprostol 25 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Prostaglandin E1 analogue
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 4154
Dosage formTablets
Oral

Misoprostol 50 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Prostaglandin E1 analogue
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 4155
Dosage formTablets
Oral

Misoprostol 600 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Prostaglandin E1 analogue
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 4261
Dosage formTablets
Oral

Pamabrom 25 mg, Paracetamol 325 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Non-opioid analgesic / antipyretic + Xanthine diuretic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 4262
Dosage formTablets
Oral

Pamabrom 50 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Xanthine diuretic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 4396
Dosage formTablets
Oral

Ritodrine Hcl 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Beta-2 agonist tocolytic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 2070
Dosage formDry-powder injectables
Parenteral

Urofollitropin 150 IU

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Women’s healthPRM 2071
Dosage formDry-powder injectables
Parenteral

Urofollitropin 75 IU

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Women’s-health agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product